TICKERNOMICS Sign up
Last Update: 2024-12-27 15:22:09
ALIGN TECHNOLOGY INC ( ALGN ) https://www.aligntech.com
213.75USD
Sector:
Healthcare
Industry:
Medical Devices
Country:
United States
1y
3y
5y
10y
Historical Returns*:
SPY
27.80%
-22.11%
ALGN
SPY
32.66%
-67.17%
ALGN
SPY
108.59%
-22.38%
ALGN
SPY
302.52%
ALGN
282.36%
*Assumes dividends reinvested
Market Stats:
Market Capitalization($MM)
Enterprise Value($MM)
Daily Volume(MM)
16063.10
15280.28
0.56
Valuation Metrics:
Price/Earnings Ratio
Price/Sales Ratio
Price/Book Value
FCF Yield(%)
Dividend Yield(%)
EV/EBITDA
36.38
4.06
4.11
1.81
0.00
19.83
Profitability Stats:
Operating Margin %(ttm)
Gross Profit %(ttm)
EBITDA Margin %(ttm)
16.60
69.72
19.35
Shareholder Value Creation:
Cost of Capital %(est)
ROIC %(ttm)
ROCE %(ttm)
Beta
10.944
10.63
15.57
1.80
Other Earnings and Cash Flow Stats:
ALIGN TECHNOLOGY INC ( ALGN ) Net Income TTM ($MM) is 441.57
ALIGN TECHNOLOGY INC ( ALGN ) Operating Income TTM ($MM) is 649.01
ALIGN TECHNOLOGY INC ( ALGN ) Owners' Earnings Annual ($MM) is 0.00
ALIGN TECHNOLOGY INC ( ALGN ) Current Price to Owners' Earnings ratio is 0.00
ALIGN TECHNOLOGY INC ( ALGN ) EBITDA TTM ($MM) is 789.65
ALIGN TECHNOLOGY INC ( ALGN ) EBITDA Margin is 19.35%
Capital Allocation:
ALIGN TECHNOLOGY INC ( ALGN ) has paid 0.00 dividends per share and bought back 1.677 million shares in the past 12 months
ALIGN TECHNOLOGY INC ( ALGN ) has reduced its debt by 185.886 million USD in the last 12 months
Capital Structure:
ALIGN TECHNOLOGY INC ( ALGN ) Interest-bearing Debt ($MM) as of last quarter is 127
ALIGN TECHNOLOGY INC ( ALGN ) Annual Working Capital Investments ($MM) are -67
ALIGN TECHNOLOGY INC ( ALGN ) Book Value ($MM) as of last quarter is 3944
ALIGN TECHNOLOGY INC ( ALGN ) Debt/Capital as of last quarter is 3%
Other Balance Sheet Stats:
ALIGN TECHNOLOGY INC ( ALGN ) has 1041 million in cash on hand as of last quarter
ALIGN TECHNOLOGY INC ( ALGN ) has 2063 million of liabilities due within 12 months, and long term debt 0 as of last quarter
ALIGN TECHNOLOGY INC ( ALGN ) has 75 common shares outstanding as of last quarter
ALIGN TECHNOLOGY INC ( ALGN ) has 0 million USD of preferred stock value
Academic Scores:
ALIGN TECHNOLOGY INC ( ALGN ) Altman Z-Score is 5.63 as of last quarter
ALIGN TECHNOLOGY INC ( ALGN ) Piotroski Score is 6.00 as of last quarter
Corporate Governance:
ALIGN TECHNOLOGY INC ( ALGN ) largest shareholder is owning shares at 0.00 ($MM) value
LARKIN C RAYMOND JR(an insider) Bought 6500 shares of ALIGN TECHNOLOGY INC ( ALGN ) for the amount of $1529645.00 on 2024-08-15
6.60% of ALIGN TECHNOLOGY INC ( ALGN ) is held by insiders, and 90.34% is held by institutions
ALIGN TECHNOLOGY INC ( ALGN ) went public on 2001-01-26
Other ALIGN TECHNOLOGY INC ( ALGN ) financial metrics:
FCF:340.00
Unlevered Free Cash Flow:0.00
EPS:6.17
Operating Margin:16.60
Gross Profit Margin:69.72
Div. Payout Ratio%:0.00
Div. Growth YoY%:0.00
Equity Return%:11.76
Beta:1.80
Buffet's Owners Earnings:0.00
Price to Owner's Earnings:0.00
About ALIGN TECHNOLOGY INC ( ALGN ) :
Align Technology, Inc. designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, China, and internationally. It operates in two segments, Clear Aligner; and Imaging Systems and CAD/CAM Services (Systems and Services). The Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of teenage patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of seven and ten years, which is a mixture of primary/baby and permanent teeth. This segment's non-comprehensive products comprise Invisalign moderate, lite and express packages, and Invisalign go and Invisalign Go Plus; and non-case products that include retention products, Invisalign training, and adjusting tools used by dental professionals during the course of treatment. The Systems and Services segment offers iTero intraoral scanning system, a single hardware platform with software options for restorative or orthodontic procedures; restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons; and software for orthodontists for digital records storage, orthodontic diagnosis, and for the fabrication of printed models and retainers. This segment also provides Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; and TimeLapse technology, which allows doctors or practitioners to compare a patient's historic 3D scans to the present-day scan, as well as subion software, disposables, rentals, leases, and pay per scan services Align Technology, Inc. was incorporated in 1997 and is headquartered in Tempe, Arizona.
User Content from Tickernomics. Created by Luminus.
DISCLAIMER

This web site and its creators are not certified financial advisors. All opinions/suggestions expressed on this website should not be treated as specific inducement to make a particular investment or follow a particular strategy, but only as an expression of an opinion.The Company doesn't warrant the information provided on the website for its completeness or accuracy, and it should not be relied upon as such. The Company is not under any obligation to update or correct any information provided on this website.The content of this website is published in the United States of America and persons who access it agree to do so in accordance with applicable U.S. law.Past performance is not indicative of future results. The Company doesn't guarantee any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment discussed on this website.Strategies or investments discussed may fluctuate in price or value. Investors may get back less than invested. Investments or strategies mentioned on this website may not be suitable for you. This material does not take into account your particular investment objectives,financial situation or needs and is not intended as recommendations appropriate for you. You must make an independent decision regarding investments or strategies mentioned on this website. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.